Monograph

Monograph designates an authoritative, comprehensive document establishing quality standards, specifications, testing procedures, and acceptance criteria for pharmaceutical substances, excipients, or finished products, published by official compendia including United States Pharmacopeia, European Pharmacopoeia, or other recognised authorities providing legally enforceable requirements ensuring medicinal product quality, safety, and consistency.

The pharmaceutical industry relies on pharmacopeial monographs throughout development, manufacturing, and quality control as a foundation for ensuring drug product quality meeting regulatory expectations. Manufacturing processes must produce materials meeting all monograph specifications, with certificates of analysis documenting compliance for each batch. Regulatory submissions reference applicable monographs establishing quality standards, with deviations requiring scientific justification. Compendial methods undergo extensive validation and standardisation enabling reproducible results across laboratories worldwide. Monograph development involves rigorous evaluation establishing appropriate specifications, with collaborative review by scientific experts from industry, academia, and regulatory agencies. Harmonisation efforts align specifications across regional pharmacopeias reducing redundant testing. As analytical technologies advance and novel therapeutic modalities emerge, monographs evolve incorporating improved methods and addressing unique quality considerations for biologics, cell therapies, and gene therapies.